Asia-Pacific Protein Degraders Market: Key Players, Clinical Pipeline & Revenue Forecast
Market Overview The global protein degrader therapeutics market, encompassing proteolysis-targeting chimeras (PROTACs) and molecular glues, was valued at approximately USD 0.5 billion in 2025 and is projected to reach USD 3.7 billion by 2035, registering a CAGR of 22% during the 2026–2035 forecast period. The market is gaining momentum as pharmaceutical and biotechnology companies...
0 Yorumlar 0 hisse senetleri 56 Views 0 önizleme